Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1α precursor on cell motility

被引:20
|
作者
Merhi-Soussi, F
Berti, M
Wehrle-Haller, B
Gabay, C
机构
[1] Univ Hosp Geneva, Dept Internal Med, Div Rheumatol, CH-1211 Geneva, Switzerland
[2] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland
关键词
cell motility ECV304 cell line; interleukin-1 alpha precursor; interleukin-1 receptor antagonist; N terminal interleukin-1 alpha propiece;
D O I
10.1016/j.cyto.2005.09.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-1 alpha, a proinflammatory cytokine, is produced as a 33 kDa protein precursor (preIL-1 alpha) which is cleaved to generate the 17 kDa C-terminal mature IL--1 alpha (mIL-1 alpha) and the 16 kDa N-terminal IL-1 alpha propiece (NIL-1 alpha). The biological effect of IL-1 alpha is regulated by the IL-1 receptor antagonist (IL-1Ra), its naturally occurring inhibitor. Four different isoforms of the IL-1Ra have been described, one secreted (sIL-1Ra) and three intracellular (icIL-1Ral1, 2, 3). Whether the icIL-1Ra1 isoform can antagonize some of the biological effects of intracellular IL-1 alpha is still unknown. The aim of this study is to investigate effects of preIL-1 alpha and icIL-1Ra1 on cell motility in stably transfected ECV304 cells. We show that expression of prelL-1 alpha in ECV304 cells significantly increases cell motility. Furthermore, transfection with NIL-la propiece also increases cell motility whereas this stimulatory effect was not observed by addition of exogenous mIL-1 alpha, suggesting an intracellular effect of preIL-1 alpha mediated by NIL-1 alpha propiece. Co-transfection of ECV304 cells with icIL-1Ra1 completely antagonizes the stimulatory effect of preIL-1 alpha and NIL-1 alpha propiece on cell motility. In conclusion, NIL-1 alpha propiece increases ECV304 cell motility and icIL-1Ra1 exerts intracellular functions regulating this stimulatory effect. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 50 条
  • [1] INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    ESPAT, NJ
    ROGY, MA
    COPELAND, EM
    MOLDAWER, LL
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) : 393 - 400
  • [2] INTERLEUKIN-1 AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
    DINARELLO, CA
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1991, 372 (04): : 239 - 239
  • [3] Interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    [J]. NUTRITION, 1995, 11 (05) : 492 - 494
  • [4] Graves' ophthalmopathy and gene polymorphisms in interleukin-1α, interleukin-1β, interleukin-1 receptor and interleukin-1 receptor antagonist
    Khalilzadeh, Omid
    Anvari, Mehdi
    Esteghamati, Alireza
    Mahmoudi, Mahdi
    Tahvildari, Maryam
    Rashidi, Armin
    Khosravi, Farideh
    Amirzargar, Aliakbar
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (06): : 614 - 619
  • [5] Induction of interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (03) : 981 - 993
  • [6] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    CLARK, BD
    MANCILLA, J
    DINARELLO, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (22) : 14147 - 14150
  • [7] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    MANCILLA, J
    CLARK, BD
    DINARELLO, CA
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A462 - A462
  • [8] Balance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in the Development of Atherosclerosis - A Polymorphism in the Interleukin-1 Receptor Antagonist -
    Iida, Shinichiro
    Komiyama, Nobuyuki
    [J]. CIRCULATION JOURNAL, 2009, 73 (08) : 1401 - 1402
  • [9] Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome
    Joseph G. Cannon
    Jonathan B. Angel
    Leslie W. Abad
    Edouard Vannier
    Maria D. Mileno
    Laura Fagioli
    Sheldon M. Wolff
    Anthony L. Komaroff
    [J]. Journal of Clinical Immunology, 1997, 17 : 253 - 261
  • [10] Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome
    Cannon, JG
    Angel, JB
    Abad, LW
    Vannier, E
    Mileno, MD
    Fagioli, L
    Wolff, SM
    Komaroff, AL
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) : 253 - 261